EDITA LUANSING: Open Payments
NPI 1598141053 · RIDGEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 44 payments from 21 companies in 2025. Trend: 2023 $750 · 2024 $781 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $143 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $95 |
| ABBVIE INC. | 3 | $51 |
| Astellas Pharma US Inc | 3 | $50 |
| Exact Sciences Corporation | 2 | $44 |
| Exeltis, USA Inc. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Radius Health, Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
Products named: Wegovy, Veozah, Cologuard Collection Kit, SLYND, EVENITY, XIFAXAN, Tymlos, Qelbree.
Industry payments across NJ — which companies pay providers there.
